Robert L. Winer

565 total citations
26 papers, 420 citations indexed

About

Robert L. Winer is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Pathology and Forensic Medicine. According to data from OpenAlex, Robert L. Winer has authored 26 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Nephrology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Robert L. Winer's work include Dialysis and Renal Disease Management (4 papers), Blood properties and coagulation (3 papers) and Parathyroid Disorders and Treatments (2 papers). Robert L. Winer is often cited by papers focused on Dialysis and Renal Disease Management (4 papers), Blood properties and coagulation (3 papers) and Parathyroid Disorders and Treatments (2 papers). Robert L. Winer collaborates with scholars based in United States. Robert L. Winer's co-authors include Ibrahim M. Eltorai, Arthur H. Cohen, David H.G. Smith, N.D. Vaziri, Sherry R. Brunnemann, Jack L. Segal, Joel M. Neutel, Nosratola D. Vaziri, Michael A. Weber and Peter Rowe and has published in prestigious journals such as Journal of the American Society of Nephrology, The Journal of Urology and American Heart Journal.

In The Last Decade

Robert L. Winer

26 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert L. Winer United States 11 107 102 76 76 75 26 420
J. L. Anderton United Kingdom 12 76 0.7× 167 1.6× 105 1.4× 48 0.6× 95 1.3× 49 483
Hitomi Tomita Japan 14 104 1.0× 104 1.0× 199 2.6× 113 1.5× 73 1.0× 24 552
P. M. KEAVEY United Kingdom 9 122 1.1× 195 1.9× 43 0.6× 41 0.5× 118 1.6× 16 388
Nancy Fenn Buderer United States 7 52 0.5× 90 0.9× 62 0.8× 63 0.8× 90 1.2× 8 593
J Przedlacki Poland 12 141 1.3× 69 0.7× 31 0.4× 58 0.8× 101 1.3× 36 515
José A. Ramirez Argentina 11 150 1.4× 112 1.1× 53 0.7× 27 0.4× 109 1.5× 25 494
J Vos Netherlands 9 198 1.9× 98 1.0× 107 1.4× 29 0.4× 76 1.0× 12 495
P Avasthi United States 12 136 1.3× 62 0.6× 48 0.6× 39 0.5× 81 1.1× 30 371
Alphan Cura Türkiye 10 86 0.8× 72 0.7× 56 0.7× 30 0.4× 114 1.5× 15 326
Harry Griffiths United Kingdom 12 30 0.3× 46 0.5× 39 0.5× 108 1.4× 195 2.6× 36 548

Countries citing papers authored by Robert L. Winer

Since Specialization
Citations

This map shows the geographic impact of Robert L. Winer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Winer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Winer more than expected).

Fields of papers citing papers by Robert L. Winer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Winer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Winer. The network helps show where Robert L. Winer may publish in the future.

Co-authorship network of co-authors of Robert L. Winer

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Winer. A scholar is included among the top collaborators of Robert L. Winer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Winer. Robert L. Winer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaziri, N.D., M.R. Pandian, Jack L. Segal, et al.. (1994). Vitamin D, parathormone, and calcitonin profiles in persons with long-standing spinal cord injury. Archives of Physical Medicine and Rehabilitation. 75(7). 766–769. 54 indexed citations
2.
Zhou, Xuehan, N.D. Vaziri, Jack L. Segal, et al.. (1993). Effects of Chronic Spinal Cord Injury and Pressure Ulcer on 25(OH)-Vitamin D Levels. PubMed. 16(1). 9–13. 26 indexed citations
3.
Neutel, Joel M., David H.G. Smith, William F. Graettinger, Robert L. Winer, & Michael A. Weber. (1993). Metabolic characteristics of hypertension: Importance of positive family history. American Heart Journal. 126(4). 924–929. 18 indexed citations
4.
Vaziri, N.D., et al.. (1993). Erythropoietin profile in spinal cord injured patients.. PubMed. 74(1). 65–7. 10 indexed citations
5.
Neutel, Joel M., et al.. (1992). Heredity and hypertension: Impact on metabolic characteristics. American Heart Journal. 124(2). 435–440. 38 indexed citations
6.
Vaziri, Nosratola D., et al.. (1992). Pressure ulcer, fibronectin, and related proteins in spinal cord injured patients.. PubMed. 73(9). 803–6. 8 indexed citations
7.
Sabo, Ana, et al.. (1990). Peritoneal Leucocyte Response to Bacterial Peritonitis in Patients Receiving Peritoneal Dialysis. The International Journal of Artificial Organs. 13(1). 44–50. 3 indexed citations
8.
9.
Winer, Robert L., Ralph E. Cutler, Allen I. Arieff, et al.. (1987). Effects of a Magnesium-Free Dialysate on Magnesium Metabolism During Continuous Ambulatory Peritoneal Dialysis. American Journal of Kidney Diseases. 10(4). 268–275. 14 indexed citations
10.
Vaziri, N.D., et al.. (1986). Extrinsic and common coagulation pathways in end-stage renal disease associated with spinal cord injury. Spinal Cord. 24(3). 154–158. 3 indexed citations
11.
Winer, Robert L., et al.. (1985). Verapamil Kinetics during Maintenance Hemodialysis. American Journal of Nephrology. 5(5). 338–341. 10 indexed citations
12.
Vaziri, Nosratola D., et al.. (1985). Intrinsic Coagulation Pathway in End‐Stage Renal Disease Associated with Spinal Cord Injury Treated with Hemodialysis. Artificial Organs. 9(2). 155–159. 4 indexed citations
13.
Morrissey, Richard, et al.. (1983). Ketoconazole Treatment of Fungal Infection in Acute Renal Failure. PubMed. 7(3). 191–196. 2 indexed citations
14.
Winer, Robert L., et al.. (1982). Preservation of normal adrenal androgen secretion in end stage renal disease. Metabolism. 31(3). 269–273. 6 indexed citations
15.
Winer, Robert L., et al.. (1979). Ultrastructural Examination of Urinary Sediment: Value in Renal Amyloidosis. American Journal of Clinical Pathology. 71(1). 36–39. 10 indexed citations
16.
Cohen, Arthur H., et al.. (1979). Diabetes Mellitus with Immune Complex Glomerulonephritis. ˜The œNephron journals/Nephron journals. 23(1). 32–37. 25 indexed citations
17.
Winer, Robert L., et al.. (1977). Sjögren's syndrome with immune-complex tubulointerstitial renal disease. Clinical Immunology and Immunopathology. 8(3). 494–503. 40 indexed citations
18.
Winer, Robert L., et al.. (1975). Segmental Renal Hypoplasia and Hypertension. The Journal of Urology. 113(4). 561–564. 8 indexed citations
19.
Weidmann, P, et al.. (1975). Role of the Renin-Angiotensin-Aldosterone System in the Regulation of Plasma Potassium in Chronic Renal Disease. ˜The œNephron journals/Nephron journals. 15(1). 35–49. 43 indexed citations
20.
Weidmann, P, et al.. (1974). [Hyporeninic hypoaldosteronism: pathogenetic importance of kidney parenchyma diseases and age].. PubMed. 104(49). 1805–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026